Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
ATRI

ATRI - Atrion Corp Stock Price, Fair Value and News

336.23USD-26.64 (-7.34%)Delayed as of 22 Feb 2024, 01:20 pm ET
Watchlist

Market Summary

USD336.23-26.64
Delayedas of 22 Feb 2024, 01:20 pm
-7.34%

ATRI Stock Price

View Fullscreen

ATRI RSI Chart

ATRI Valuation

Market Cap

638.6M

Price/Earnings (Trailing)

29.97

Price/Sales (Trailing)

3.79

EV/EBITDA

13.99

Price/Free Cashflow

-33.29

ATRI Price/Sales (Trailing)

ATRI Profitability

Operating Margin

49.47%

EBT Margin

14.18%

Return on Equity

8.87%

Return on Assets

8.05%

Free Cashflow Yield

-3%

ATRI Fundamentals

ATRI Revenue

Revenue (TTM)

168.6M

Rev. Growth (Yr)

-6.09%

Rev. Growth (Qtr)

-4.4%

ATRI Earnings

Earnings (TTM)

21.3M

Earnings Growth (Yr)

-66.75%

Earnings Growth (Qtr)

-55.22%

Breaking Down ATRI Revenue

52 Week Range

336.23682.80
(Low)(High)

Last 7 days

-7.2%

Last 30 days

0.3%

Last 90 days

18.2%

Trailing 12 Months

-48.1%

How does ATRI drawdown profile look like?

ATRI Financial Health

Current Ratio

7.58

ATRI Investor Care

Dividend Yield

2.38%

Dividend/Share (TTM)

8.65

Buy Backs (1Y)

0.72%

Diluted EPS (TTM)

12.09

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023176.4M171.3M168.6M0
2022173.0M179.2M180.9M183.5M
2021143.2M147.9M157.0M165.0M
2020157.0M154.9M149.8M147.6M
2019154.7M155.9M155.5M155.1M
2018147.5M150.2M151.5M152.4M
2017145.8M145.8M145.9M146.6M
2016143.6M142.1M142.6M143.5M
2015142.7M145.3M146.1M145.7M
2014134.9M137.3M139.9M140.8M
2013123.3M125.2M128.6M132.0M
2012116.4M115.9M116.1M119.1M
2011112.3M115.5M118.8M117.7M
2010102.6M104.6M106.6M108.6M
2009000100.6M

Tracking the Latest Insider Buys and Sells of Atrion Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Dec 01, 2023
athey preston g
bought
95,904
319
300
-
Nov 16, 2023
battat david a
bought
90,000
300
300
president & ceo
Sep 20, 2023
bankes jeannette
acquired
82,589
444
186
-
Aug 15, 2023
athey preston g
bought
104,670
523
200
-
Aug 15, 2023
athey preston g
acquired
104,670
523
200
-
Jul 01, 2023
battat david a
acquired
-
-
310
president & ceo
Jul 01, 2023
battat emile a
back to issuer
-175,870
565
-310
director,chairman of the board
Jul 01, 2023
battat david a
back to issuer
-175,870
565
-310
president & ceo
Jul 01, 2023
battat emile a
acquired
-
-
310
director,chairman of the board
May 23, 2023
spaulding ronald nicholas
acquired
-
-
224
-

1–10 of 50

Which funds bought or sold ATRI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 16, 2024
PRICE T ROWE ASSOCIATES INC /MD/
added
0.43
-252,000
2,925,000
-%
Feb 15, 2024
Baker Avenue Asset Management, LP
sold off
-100
-413
-
-%
Feb 15, 2024
Legal & General Group Plc
reduced
-0.21
-49,508
531,822
-%
Feb 15, 2024
JANE STREET GROUP, LLC
new
-
211,744
211,744
-%
Feb 15, 2024
TOWNSQUARE CAPITAL LLC
added
10.89
7,256
443,563
0.01%
Feb 15, 2024
BARCLAYS PLC
added
356
673,000
885,000
-%
Feb 14, 2024
CRAWFORD INVESTMENT COUNSEL INC
added
13.63
251,189
6,268,600
0.13%
Feb 14, 2024
Ameritas Investment Partners, Inc.
unchanged
-
-4,710
51,894
-%
Feb 14, 2024
COMERICA BANK
reduced
-40.14
-80,429
97,852
-%
Feb 14, 2024
DF DENT & CO INC
added
45.89
3,886,250
15,401,500
0.20%

1–10 of 50

Are Funds Buying or Selling ATRI?

Are funds buying ATRI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ATRI
No. of Funds

Unveiling Atrion Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
t. rowe price investment management, inc.
6.6%
115,477
SC 13G
Feb 13, 2024
kayne anderson rudnick investment management llc
11.07%
194,800
SC 13G/A
Feb 12, 2024
neuberger berman group llc
10.40%
183,012
SC 13G/A
Jan 29, 2024
blackrock inc.
6.6%
115,446
SC 13G/A
Feb 14, 2023
price t rowe associates inc /md/
0.5%
8,777
SC 13G/A
Feb 14, 2023
t. rowe price investment management, inc.
6.5%
115,570
SC 13G
Feb 14, 2023
kayne anderson rudnick investment management llc
10.76%
190,681
SC 13G/A
Feb 10, 2023
neuberger berman group llc
10.99%
194,910
SC 13G/A
Feb 01, 2023
blackrock inc.
6.4%
113,355
SC 13G/A
Feb 14, 2022
kayne anderson rudnick investment management llc
10.58%
190,555
SC 13G/A

Recent SEC filings of Atrion Corp

View All Filings
Date Filed Form Type Document
Feb 14, 2024
SC 13G
Major Ownership Report
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 12, 2024
SC 13G/A
Major Ownership Report
Jan 29, 2024
SC 13G/A
Major Ownership Report
Jan 03, 2024
4
Insider Trading
Jan 03, 2024
4
Insider Trading
Dec 28, 2023
8-K
Current Report
Dec 01, 2023
4
Insider Trading
Nov 27, 2023
4
Insider Trading
Nov 20, 2023
4/A
Insider Trading

What is the Fair Value of ATRI?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to Atrion Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
205.1B
40.1B
0.08% 5.41%
35.84
5.11
-8.12% -17.45%
70.9B
19.5B
1.90% -2.48%
56.45
3.64
4.02% -22.04%
23.3B
3.8B
13.67% -2.23%
64.31
6.13
-1.48% -28.97%
21.5B
14.9B
3.05% 1.38%
8.08
1.43
2.01% 209.17%
MID-CAP
9.9B
2.7B
6.89% -27.73%
-15.59
3.72
-4.68% 82.43%
9.8B
12.7B
2.56% -12.12%
21.93
0.77
0.68% -30.25%
9.2B
3.5B
8.76% 25.90%
32.49
2.65
4.97% 18.89%
7.0B
3.9B
-8.15% -6.44%
-32
1.78
-2.62% 73.16%
3.4B
342.6M
-1.40% 20.18%
-286.65
10.04
42.19% 84.12%
2.6B
6.6B
-4.32% -4.67%
12.92
0.39
2.61% 0.52%
SMALL-CAP
968.4M
3.1B
8.08% -63.68%
-2.27
0.31
7.95% -543.98%
360.5M
163.3M
8.18% -20.52%
-14.67
2.21
7.14% -56.09%
234.7M
329.5M
3.17% -52.24%
-16.63
0.71
0.49% 64.22%
70.0M
50.3M
4.50% -30.54%
-4.62
1.39
3.23% 20.81%
4.5M
3.7M
-15.66% 215.09%
-0.36
1.19
5.77% 8.23%

Atrion Corp News

Latest updates
InvestorsObserver27 hours ago
MarketBeat13 Feb 202409:44 pm
Simply Wall St09 Feb 202408:00 am
Markets Insider28 Dec 202308:00 am
Quartz3 months ago

Atrion Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue-4.4%42.0044.0040.0043.0045.0049.0047.0040.0043.0043.0039.0032.0034.0038.0044.0034.0039.0040.0042.0035.0039.00
Cost Of Revenue---------------24.0019.0021.0022.0023.0019.0021.00
Gross Profit-20.4%14.0017.0015.0018.0018.0021.0019.0017.0018.0018.0016.0014.0015.0017.0020.0016.0018.0019.0019.0016.0018.00
Operating Expenses-2.1%10.0010.0011.009.008.0010.009.0010.008.008.007.008.007.007.008.007.007.008.008.007.007.00
  S&GA Expenses1.3%2.002.003.002.002.003.003.002.002.002.002.002.002.002.002.002.002.002.002.002.002.00
  R&D Expenses16.3%2.002.002.001.001.002.001.002.001.001.001.001.001.001.002.001.001.001.001.001.001.00
EBITDA Margin-100.0%-0.26*0.27*0.30*0.30*0.37*0.30*0.31*0.55*0.51*0.43*0.34*0.46*0.44*0.43*0.35*0.18*----
Interest Expenses259.3%0.000.00-------------------
Income Taxes-154.5%-0.571.001.007.00-1.742.002.003.001.00-2.022.0012.00-1.320.000.002.001.004.00-2.393.002.00
Earnings Before Taxes-53.9%4.008.004.009.0011.0011.0010.009.0010.0011.009.008.009.0011.0011.0042.00-1.48-2.0412.009.0011.00
EBT Margin-21.6%0.14*0.18*0.20*0.22*0.22*0.22*0.23*0.23*0.24*0.25*0.26*0.26*---------
Net Income-55.2%3.007.003.008.009.009.008.008.008.009.008.007.007.009.009.008.0010.0010.009.008.009.00
Net Income Margin-20.4%0.13*0.16*0.17*0.19*0.19*0.19*0.20*0.20*0.21*0.21*0.22*0.22*---------
Free Cashflow124.2%2.00-9.76-3.21-8.571.00-1.184.006.00-23.99-28.16-29.38-26.31---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets-0.8%265267261265272275272267269268269267263260260262257249241231228
  Current Assets-0.2%116116115119133138139137134126120112113102128132145133125122121
    Cash Equivalents112.9%1.000.005.005.0027.0016.0025.0032.0024.0017.0029.0022.0024.0024.0044.0045.0064.0050.0044.0059.0050.00
  Inventory3.4%83.0080.0075.0066.0060.0054.0051.0051.0047.0048.0050.0050.0049.0046.0041.0042.0038.0035.0033.0034.0032.00
  Net PPE-0.7%12712812512411510910298.0097.0096.0095.0095.0091.0088.0085.0085.0082.0080.0076.0075.0072.00
  Goodwill0%10.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.00
Liabilities----25.0025.0024.0024.0023.0024.0025.0026.0026.0026.0025.0025.0024.0023.0022.0021.0020.0020.00
  Current Liabilities-7.1%15.0016.0017.0018.0018.0019.0016.0013.0015.0013.0011.0014.0013.0015.0013.0011.0011.0011.0011.0010.0012.00
Shareholder's Equity-0.3%240241239240246246246244239241245240238234235238232225218211205
  Retained Earnings-0.2%379380377378373368362357353348342338334329324318313306299292287
  Additional Paid-In Capital0.3%67.0067.0066.0066.0066.0066.0062.0061.0061.0060.0060.0054.0054.0053.0052.0052.0052.0051.0051.0050.0050.00
Accumulated Depreciation2.4%157154150147144141138135133129126124122120119116114111109107105
Shares Outstanding-0.1%2.002.002.002.002.002.002.002.002.002.002.002.00---------
Float------870---874---905---1,228---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations1006.0%5,418-5984,328-15810,6106,49011,8479,97312,7978,6247,40410,4719,3266,59212,8316,30012,03311,22712,90510,54511,778
  Share Based Compensation-55.7%280632407207202791530546428841497191549613378376326600380362380
Cashflow From Investing30.0%-1,845-2,635-77.00-7,0849,184-5,105-12,2782,1463,800-7,3073,357-7,030-6,228-15,888-1,686-22,0504,913-2,585-25,1146784,691
Cashflow From Financing-215.8%-3,224-1,021-4,419-15,152-9,106-9,834-6,947-3,511-10,011-13,674-3,784-4,987-3,201-10,685-12,113-2,875-2,875-3,083-2,501-2,501-2,501
  Dividend Payments2.3%3,8723,7843,784-3,8373,4873,500------14,6132,8382,86818,635-12,8852,5042,5012,5012,501
  Buy Backs-98.4%17.001,037613-5,0905,8933,447-33,9766,500-8,718-7,392-1,794--7,792-9,245------

ATRI Income Statement

2023-09-30
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)    
Revenues$ 41,911$ 44,631$ 125,742$ 140,651
Cost of goods sold28,17526,97879,67182,921
Gross profit13,73617,65346,07157,730
Operating expenses:    
Selling2,3482,3067,3927,451
General and administrative5,4534,49317,65815,217
Research and development1,8691,2515,1064,180
Total operating expense9,6708,05030,15626,848
Operating income4,0669,60315,91530,882
Interest and dividend income320210687639
Other investment income/(losses)(782)764(1,405)216
Other income073992
Interest Expense(97)0(124)0
Total other income expense(559)981(803)947
Income before provision for income taxes3,50710,58415,11231,829
Provision for income taxes(568)(1,745)(2,125)(5,143)
Net income$ 2,939$ 8,839$ 12,987$ 26,686
Net income per basic share$ 1.67$ 4.95$ 7.38$ 14.89
Weighted average basic shares outstanding1,7601,7861,7611,793
Net income per diluted share$ 1.67$ 4.94$ 7.37$ 14.86
Weighted average diluted shares outstanding1,7611,7881,7621,796
Dividends per common share$ 2.20$ 2.15$ 6.50$ 6.05

ATRI Balance Sheet

2023-09-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 658$ 4,731
Short-term investments3,83921,152
Accounts receivable23,29023,951
Inventories82,94665,793
Prepaid expenses and other current assets5,0103,770
Total current assets115,743119,397
Long-term investments9,4748,669
Property, plant and equipment284,079270,642
Less accumulated depreciation and amortization157,313146,888
Property plant and equipment net126,766123,754
Other assets and deferred charges:  
Patents and licenses1,1001,185
Goodwill9,7309,730
Other1,9961,977
Total other assets and deferred charges12,82612,892
Total assets264,809264,712
Current liabilities:  
Accounts payable and accrued liabilities13,91518,024
Accrued income and other taxes1,35174
Total current liabilities15,26618,098
Line of credit4,5000
Other non-current liabilities4,8617,073
Stockholders' equity:  
Common stock, par value $0.10 per share; authorized 10,000 shares, issued 3,420 shares342342
Additional paid-in capital67,16566,347
Retained earnings379,213377,682
Treasury shares,1,660 at September 30, 2023 and 1,659 at December 31, 2022, at cost(206,538)(204,830)
Total stockholders' equity240,182239,541
Total liabilities and stockholders' equity$ 264,809$ 264,712
ATRI
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of specialized medical devices that include disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
 CEO
 WEBSITEwww.atrioncorp.com
 EMPLOYEES722

Atrion Corp Frequently Asked Questions


What is the ticker symbol for Atrion Corp? What does ATRI stand for in stocks?

ATRI is the stock ticker symbol of Atrion Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Atrion Corp (ATRI)?

As of Wed Feb 21 2024, market cap of Atrion Corp is 638.59 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ATRI stock?

You can check ATRI's fair value in chart for subscribers.

What is the fair value of ATRI stock?

You can check ATRI's fair value in chart for subscribers. The fair value of Atrion Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Atrion Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ATRI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Atrion Corp a good stock to buy?

The fair value guage provides a quick view whether ATRI is over valued or under valued. Whether Atrion Corp is cheap or expensive depends on the assumptions which impact Atrion Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ATRI.

What is Atrion Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Feb 21 2024, ATRI's PE ratio (Price to Earnings) is 29.97 and Price to Sales (PS) ratio is 3.79. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ATRI PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Atrion Corp's stock?

In the past 10 years, Atrion Corp has provided 0.03 (multiply by 100 for percentage) rate of return.